> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ANDA Approval Withdrawal Notice Corrected
- URL: https://www.fdaweb.com/anda-approval-withdrawal-notice-corrected/
- Published: 2021-10-04T12:00:00.000Z
- Updated: 2026-09-14T17:17:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150277

*Federal Register* notice: FDA is correcting a notice that appeared in the 6/25 *Federal* Register and announced the approval withdrawal of 36 ANDAs from multiple applicants. Yung Shin Pharmaceutical subsequently notified the agency about not withdrawing ANDA 065152, cephalexin capsules, and this notice states its approval is still in effect. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-10-01/pdf/2021-21371.pdf?ref=fdaweb.com).